Well I do think they'll stick pretty close to the plan outlined. I imagine we'll have to get some direct financing pretty quick here. Adding these impressive people to our subs who both are already so familiar with the asset makes potential investment more reliable and more turnkey. To design and prepare for the trial, we need a reliable budget. For them to give us the money, they need to know who will use it and how.
(3)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links